885 Targeting FPR2 as a novel approach for immunotherapy in pancreatic cancer female patients - studies of sexual immune dimorphism in the tumor microenvironment

• Carlos Fernández Moro,
• Matthias Löhr,
• Fei He,
• Dhifaf Sarhan,
• Marit Melssen,
• Ahmed Calandigary,
• Enana Malki,
• Marina Kaisso,
• Peter Olofsson-Sahl,
• Mikael Karlsson,
• Rainer Heuchel

Affiliations

Carlos Fernández Moro

5 Division of Pathology, Department of Laboratory Medicine (LABMED), Karolinska Institutet, Huddinge, Sweden

Matthias Löhr

Aff1 grid.4714.60000000419370626Karolinska Institutet Stockholm Sweden

Fei He

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China

Dhifaf Sarhan

Aff1 grid.4714.60000000419370626Karolinska Institutet Stockholm Sweden

Marit Melssen

Aff459 grid.27755.32000000009136933XUniversity of Virginia Charlottesville VA USA

Ahmed Calandigary

Karolinska Institutet, Stockholm, Sweden

Enana Malki

Karolinska Institutet, Stockholm, Sweden

Marina Kaisso

Karolinska Institutet, Stockholm, Sweden

Peter Olofsson-Sahl

Karolinska Institutet, Stockholm, Sweden

Mikael Karlsson

Karolinska Institutet, Stockholm, Sweden

Rainer Heuchel

Karolinska Institutet, Stockholm, Sweden